Genetic testing ordered within a week of life confirmed PHA type 1 with a homozygous pathogenic frameshift variant in <i>SCNN1A</i> c.575delA (p.Arg192GlyfsX57). Here, SCNN1A is linked to pseudohypoaldosteronism type 1.